发明名称 PROTEASE ASSAY
摘要 The present invention provides a diagnostic reagent or assay for assessing the activity of a protease in vivo or in vitro and methods of detecting the presence of a cancerous or precancerous cell. The assays are comprised of two particles linked via an oligopeptide linkage that comprises a consensus sequence specific for the target protease. Cleavage of the sequence by the target protease can be detected visually or using various sensors, and the diagnostic results can be correlated with cancer prognosis.
申请公布号 US2015132230(A1) 申请公布日期 2015.05.14
申请号 US201514605083 申请日期 2015.01.26
申请人 Kansas State University Research Foundation 发明人 Bossmann Stefan H.;Troyer Deryl L.;Basel Matthew T.
分类号 A61K49/00 主分类号 A61K49/00
代理机构 代理人
主权项 1. A method for detecting the activity of a protease associated with a cancerous or precancerous cell in a mammal comprising: (a) administering to the mammal a composition comprising a diagnostic assay including a nanoplatform assembly and a pharmaceutically-acceptable carrier, said nanoplatform assembly comprising: a first particle;a second particle; anda linkage between said first and second particles, wherein said linkage comprises a protease consensus sequence; (b) activating the assay in said composition; (c) exposing a region of the mammal suspected of having a cancerous or precancerous cell to an energy source; and (d) detecting changes in an absorption or emission spectrum of the assay, wherein said changes correspond to protease activity.
地址 Manhattan KS US